Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
LSE:ARIX
Price:
142
GBX
Market Closed
Market Cap:
£183.7m
Relative Value
There is not enough data to reliably calculate the relative value of ARIX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ARIX
Relative Value
Base Case
Not Available
Multiples Across Competitors
ARIX Competitors Multiples
Arix Bioscience PLC Competitors
Arix Bioscience PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Arix Bioscience PLC
LSE:ARIX
|
183.8m GBP | 2 387.1 | 12.3 | -14.2 | -13.7 | |
| US |
|
BlackRock Inc
NYSE:BLK
|
148.5B USD | 6.1 | 26.7 | 18 | 20.8 | |
| US |
|
Blackstone Inc
NYSE:BX
|
134.7B USD | 9.3 | 44.6 | 19.8 | 19.9 | |
| CA |
|
Brookfield Corp
NYSE:BN
|
94.8B USD | 1.3 | 83.1 | 11.1 | 16.5 | |
| ZA |
N
|
Ninety One Ltd
JSE:NY1
|
86.9B ZAR | 5.7 | 25.5 | -37.4 | -40.3 | |
| US |
|
KKR & Co Inc
NYSE:KKR
|
80.2B USD | 3.9 | 35.8 | 259 | 259 | |
| US |
|
Bank of New York Mellon Corp
NYSE:BK
|
79.1B USD | 4 | 15 | 0 | 0 | |
| CA |
|
Brookfield Asset Management Inc
NYSE:BAM
|
70.3B USD | 14.6 | 28.3 | 25.6 | 26 | |
| CA |
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
96.3B CAD | 14.6 | 28.3 | 25.6 | 26 | |
| US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
61.3B EUR | 14.7 | 28.5 | 25.8 | 26.2 | |
| US |
|
Ameriprise Financial Inc
NYSE:AMP
|
40.1B USD | 2.1 | 11.2 | 11.9 | 11.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
